Skip to main content
. 2014 Apr 29;2014:659726. doi: 10.1155/2014/659726

Table 1.

Patient characteristics, previous history of splenectomy, imaging studies, and laboratory results.

Patient number/age (y)/sex Underlying prothrombotic disorders Imaging studies TBIL
(μmol/L)
ALT
(U/L)
AST
(U/L)
ALP
(U/L)
WBC
(109/L)
Platelet
(109/L)
Splenectomy
1/35/F N/A Total occluded MPV and SMV 10.2 12 15 79 4.94 122 Yes

2/24/M N/A Partial occluded MPV 9.4 23 50 73 2.76 45 Yes

3/39/M N/A Total occluded MPV and SV and partial occluded SMV 11.3 11 25 75 9.77 6 No

4/19/M Antithrombin III deficiency, thrombocytosis Total occluded MPV 15.3 57 86 59 1.83 472 Yes

5/25/F Protein C deficiency, antithrombin III deficiency Total occluded MPV and partial occluded SMV and SV 36.4 37 32 166 4.37 25 No

6/26/M N/A Partial occluded MPV 10.4 17 25 112 2.51 71 Yes

7/25/F Thrombocytosis Total occluded MPV 6.4 29 33 70 2.63 653 Yes

8/40/M Antithrombin III deficiency Partial occluded MPV 7.7 19 26 96 4.17 216 No

9/21/F No Total occluded MPV and SMV 15.6 29 19 101 14.26 185 Yes

10/19/M Antithrombin III deficiency Total occluded MPV and partial occluded SMV 19.6 16 33 68 3.41 51 No

11/34/M Protein C deficiency Total occluded MPV, partial occluded SMV and SV 13.8 13 26 72 2.42 52 No

12/45/M No Total occluded MPV and SMV 19 13 21 145 2.15 277 Yes

13/31/M Thrombocytosis Total occluded MPV and SMV 10.8 15 23 67 1.27 517 Yes

14/29/M FVL mutation, protein C deficiency Total occluded MPV and partial occluded SMV 6 26 24 63 3.54 189 Yes

15/24/M Protein S deficiency Partial occluded MPV 8.1 10 16 38 7.68 92 No

TBIL: total bilirubin, ALT: alanine aminotransferase, AST: aspartate aminotransferase, ALP: alkaline phosphatase, WBC: white blood cell, MPV: main portal vein, SMV: superior mesenteric vein, SV: splenic vein, and FVL mutation: Factor V Leiden mutation.